Stay updated on Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial
Sign up to get notified when there's something new on the Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial page.

Latest updates to the Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial page
- Check13 days agoChange DetectedNo significant additions or deletions detected on the Study Details page for NCT02892123. The page content appears unchanged between the two screenshots.SummaryDifference0.3%

- Check35 days agoChange DetectedUpgrade to v3.2.0 with a critical operating-status notice; removes the previous v3.1.0 version reference.SummaryDifference3%

- Check42 days agoChange DetectedRelease update to v3.1.0 with removal of Ovarian cancer resource from GARD and removal of v3.0.2 reference.SummaryDifference0.4%

- Check57 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; 'Back to Top' was removed.SummaryDifference0.2%

- Check65 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check72 days agoChange DetectedThe web page has been updated to include new drug information for various cancer treatments, including specific drugs like Paclitaxel and Tucatinib, as well as resources related to ovarian cancer and other cancer types. Additionally, the facility name and location details have been added, while some previous location and resource information has been removed.SummaryDifference8%

Stay in the know with updates to Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial page.